Anticorpo monoclonal hla-dr-pb - (clone l 243) CD71 apc-H7 bdm-A712 tcr gama/delta pecy 7 bd bulklysis (20 testes) CD45RA apc bd oneflow lymphoid screening tube, 20 testes GD2 apc clone 14. G2A bd anti-human CD99 fitc (clone TU12)

Contracting body

Instituto Português de Oncologia do Porto Francisco Gentil, E. P. E.

Awardee

Enzifarma - Diagnóstica e Farmacêutica, S. A.

Place of performance

Portugal, Porto, Porto

NUTS region

PT11A - Área Metropolitana do Porto

Contract price

€8,513.77

Procedure base price

€8,513.77

Total effective price

Not reported on Portal BASE

Publication date

21 June 2024

Award date

5 June 2024

Signing date

5 June 2024

Performance period

20 days

The contract price is the value agreed in the contract, not the amount paid.

Contract type

Aquisição de bens móveis

Procedure type

Direct award, general (Ajuste Direto Regime Geral)

Award criterion

Monofator

CPV code

33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais

Legal basis

Artigo 24.º, n.º 1, alínea c) do Código dos Contratos Públicos

Regime

Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05

Framework agreement

Not stated

Centralised procedure

No

Environmental criterion

No

Notice

Not stated

Procedure identifier

7104453